MRK · News · 20261103N

Revenue Performance and Mix

Merck & Co., Inc. · 2026-11-03 · Importance 75 · Surprise 60

A third-party report cited Merck’s third-quarter 2026 sales of US$18.1 billion. The report said Merck raised its full-year 2026 sales guidance to US$66.8 billion–US$67.3 billion. It also characterized pipeline execution as important to supporting future revenue as KEYTRUDA approaches eventual loss of exclusivity.

Key facts

• Merck’s reported third-quarter sales were US$18.1 billion, and the company raised its 2026 sales guidance to US$66.8 billion–US$67.3 billion. source
• Merck’s stock was reported at 48,000.00 ARS, down 2.79% as of the November 3 market close. source
• A separate report listed Merck’s stock at 48,000.00 ARS, down 2.79%. source